These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20662898)

  • 21. [Diffuse normolipemic plane xanthomas associated with monoclonal gammopathy of undetermined significance].
    Liuti F; Hernández-Hernández Z; Soler-Cruz E; Fernández-de-Misa R; Almeida-Martín P
    Rev Clin Esp (Barc); 2014 Apr; 214(3):e27-8. PubMed ID: 24629209
    [No Abstract]   [Full Text] [Related]  

  • 22. Systemic manifestations of monoclonal gammopathy.
    Decaux O; Laurat E; Perlat A; Cazalets C; Jego P; Grosbois B
    Eur J Intern Med; 2009 Sep; 20(5):457-61. PubMed ID: 19712843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coagulation disorders in patients with monoclonal gammopathies.
    Keren DF
    Hematol Oncol Clin North Am; 1993 Dec; 7(6):1153-9. PubMed ID: 8294313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diffuse plane normolipaemic xanthomatosis as a manifestation of monoclonal gammopathy.
    Morsink LM; Nijhof IS
    Br J Haematol; 2019 Nov; 187(4):411. PubMed ID: 31407310
    [No Abstract]   [Full Text] [Related]  

  • 25. CD45RA+ and CD45RO+ lymphocyte subpopulations in patients with monoclonal gammopathies: correlations with diagnosis, clinical stage and treatment status.
    Raya Sánchez JM; Nieto LH; Brito Barroso ML; González Brito G; del Mar Caballero Gómez M
    Haematologica; 2004 Jun; 89(6):755-6. PubMed ID: 15194547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
    Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M
    Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Monoclonal gammopathies of undetermined significance. Clinical course and biological aspects of 397 cases].
    Giraldo MP; Rubio-Félix D; Perella M; Gracía JA; Bergua JM; Giralt M
    Sangre (Barc); 1991 Oct; 36(5):377-82. PubMed ID: 1816635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Skin changes in paraproteinemias (monoclonal gammopathies)].
    Merk H; Goerz G
    Hautarzt; 1984 Mar; 35(3):126-31. PubMed ID: 6715167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Necrobiotic xanthogranuloma associated with lymphoplasmacytic lymphoma. Palliative treatment with carbon dioxide laser.
    Vieira V; Del Pozo J; Martínez W; Veiga-Barreiro JA; Fonseca E
    Eur J Dermatol; 2005; 15(3):182-5. PubMed ID: 15908304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Monoclonal gammopathies in a regional hospital: a 6-year analysis].
    Page del Pozo MA; Herrero Huerta F; Martínez Alfaro E; Campillo Fuentes J; Campos Aranda M; García Puche MJ
    Rev Clin Esp; 1988 Sep; 183(4):180-3. PubMed ID: 3244870
    [No Abstract]   [Full Text] [Related]  

  • 31. [The first experience of external quality control of immunohistochemical studies in the diagnosis of lymphoproliferative diseases].
    Krivolapov IuA; Peshkov MV; Leenman EE; Matsionis AE; Kovrigina AM
    Arkh Patol; 2011; 73(2):25-32. PubMed ID: 21695985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Lymphoproliferative disorders after liver transplantation].
    Pageaux GP
    Gastroenterol Clin Biol; 2001 Apr; 25(4):357-66. PubMed ID: 11449124
    [No Abstract]   [Full Text] [Related]  

  • 33. [Lymphoproliferative syndrome in a 87-year-old patient: leukemic phase of mantle cell lymphoma or chronic lymphoid leukemia].
    André E; Klapczynski F; Siguret V; Bornand A; Gaussem P
    Ann Biol Clin (Paris); 1997; 55(3):235-7. PubMed ID: 9238426
    [No Abstract]   [Full Text] [Related]  

  • 34. The use of monoclonal antibodies on paraffin sections in the diagnosis of cutaneous lymphoproliferative disorders.
    Cerroni L; Kerl H
    Dermatol Clin; 1994 Apr; 12(2):219-29. PubMed ID: 8045034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycosis fungoides associated with dystrophic xanthomatosis.
    McCadden ME; Glick AD; King LE
    Arch Dermatol; 1987 Jan; 123(1):91-4. PubMed ID: 3800428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diffuse, ulcerating plaques and nodules. Necrobiotic xanthogranuloma (NXG) with paraproteinemia.
    Furner BB; Stevens CS
    Arch Dermatol; 1989 Feb; 125(2):287-8, 290. PubMed ID: 2913965
    [No Abstract]   [Full Text] [Related]  

  • 37. Paraproteinaemic neuropathy.
    Thomas PK; Willison HJ
    Baillieres Clin Neurol; 1994 Apr; 3(1):129-47. PubMed ID: 7921586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of diffuse plane normolipemic xanthomatosis associated with pancytopenia and monoclonal gammopathy.
    Kourou K; Suga Y; Muramatsu S; Yaguchi H; Ogawa H
    J Dermatol; 2006 Jan; 33(1):64-7. PubMed ID: 16469089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An approach to practical problems in the diagnosis of lymphoproliferative disorders using cytochemistry and immunocytochemistry.
    Beckstead JH
    Clin Lab Med; 1988 Mar; 8(1):211-22. PubMed ID: 3282760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Lipid composition of cutaneous lesions in different types of xanthomatosis].
    Ferrando J; Corominas Vilardell A
    Med Cutan Ibero Lat Am; 1977; 5(6):415-24. PubMed ID: 368463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.